Search Results - "Seida, Adel A"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2

    Expression profile of genes related to pregnancy maintenance in Dromedary Camel during the first trimester by Adel, Ola, Ibrahim, Sally, Mahmoud, Karima, Galal, Samaa M., Fathi, Mohamed, Seida, Adel A.M.

    Published in Animal reproduction science (01-04-2023)
    “…So far, few signals involved in embryo-maternal dialogue have been identified in pregnant she-camel. Our objective was to investigate expression profiles of…”
    Get full text
    Journal Article
  3. 3

    Dynamics of uterine and ovarian arteries flow velocity waveforms and their relation to follicular and luteal growth and blood flow vascularization during the estrous cycle in Friesian cows by Abdelnaby, Elshymaa A., Abo El-Maaty, Amal M., Ragab, Refaat S.A., Seida, Adel A.

    Published in Theriogenology (01-11-2018)
    “…Doppler ultrasonography enabled understanding of the reproductive system hemodynamics in cyclic and pregnant cattle. To confirm the hypothesis that the…”
    Get full text
    Journal Article
  4. 4

    Expression profile of viability and stress response genes as a result of resveratrol supplementation in vitrified and in vitro produced cattle embryos by Saber, Yasser H.A., Ibrahim, Sally, Mahmoud, Karima Gh. M., Ahmed, Wahid M., Ragab, Refaat S.A., Seida, Adel A.M.

    Published in Molecular biology reports (01-12-2024)
    “…Background Resveratrol, a potent antioxidant, is known to induce the up-regulation of the internal antioxidant system. Therefore, it holds promise as a method…”
    Get full text
    Journal Article
  5. 5

    Caffeine supplementation during IVM improves frequencies of nuclear maturation and preimplantation development of dromedary camel oocytes following IVF by Fathi, Mohamed, Seida, Adel A., Sobhy, Refaat R., Darwish, Gamal M., Badr, Magdy R., Moawad, Adel R.

    Published in Theriogenology (01-06-2014)
    “…Caffeine supplementation during oocyte IVM has been reported to improve preimplantation embryo development and the quality of in vitro–produced blastocysts in…”
    Get full text
    Journal Article
  6. 6

    Assessment of Uterine Vascular Perfusion During the Estrous Cycle of Mares in Connection to Circulating Leptin and Nitric Oxide Concentrations by Abdelnaby, Elshymaa A., Abo El-Maaty, Amal M., Ragab, Refaat S.A., Seida, Adel A.

    Published in Journal of equine veterinary science (01-04-2016)
    “…The objective of this study was to find difference in vascular perfusion of uterine horns or uterine body throughout the estrous cycle and their relation to…”
    Get full text
    Journal Article
  7. 7

    Therapie von Brustkrebsstammzellen beim HER2 positiven Mammakarzinom mit HER2 spezifischen Antikörpern (T-DM1 und Pertuzumab) by Hönig, A, Reim, F, Junker, M, Bruttel, V, Chandran, A, Montalban, I, Dietl, J, Adel Seida, A, Wischhusen, J, Diessner, J

    Published in Geburtshilfe und Frauenheilkunde (30-08-2011)
    “…Trastuzumab (Herceptin®) hat das Gesamtüberleben von Patienten mit HER2-positivem-Brustkrebs entscheidend verbessert. Die Antikörper-abhängige Zelltoxizität…”
    Get full text
    Conference Proceeding Journal Article
  8. 8

    Hemmung der Induktion von Tumorstammzellen by Diessner, J, Reim, F, Junker, M, Bruttel, V, Chandran, A, Montalban, I, Dietl, J, Adel Seida, A, Wischhusen, J, Hönig, A

    Published in Geburtshilfe und Frauenheilkunde (30-08-2011)
    “…Tumorstammzellen (CSC) bilden nur einen kleinen Teil der Population eines Tumors. Dennoch sind sie entscheidend für die Metastasierung und Therapieresistenz…”
    Get full text
    Conference Proceeding Journal Article
  9. 9

    Hemmung der Induktion von Tumorstammzellen by Diessner, J, Reim, F, Junker, M, Bruttel, V, Chandran, A, Montalban, I, Dietl, J, Adel Seida, A, Wischhusen, J, Hönig, A

    Published in Geburtshilfe und Frauenheilkunde (06-06-2011)
    “…Tumorstammzellen (CSC) bilden nur einen kleinen Teil der Population eines Tumors. Dennoch sind sie entscheidend für die Metastasierung und Therapieresistenz…”
    Get full text
    Conference Proceeding Journal Article
  10. 10

    Therapie von Brustkrebstammzellen beim HER2 positiven Mammakarzinom mit HER2 spezifischen Antikörpern (T-DM1 und Pertuzumab) by Diessner, J, Reim, F, Junker, M, Bruttel, V, Chandran, A, Montalban, I, Dietl, J, Adel Seida, A, Wischhusen, J, Hönig, A

    Published in Geburtshilfe und Frauenheilkunde (06-06-2011)
    “…Trastuzumab (Herceptin®) hat das Gesamtüberleben von Patienten mit HER2 positivem Brustkrebs entscheidend verbessert. Die Antikörper-abhängige Zelltoxizität…”
    Get full text
    Conference Proceeding Journal Article